Combining design and clinical expertise
SureflO2 - Making the invisible visible
SureflO2 – traditional oxygen masks reimagined

Title image


Flow Indicator Oxygen Mask

Visual Gas Flow Indicator

SureflO2® is an integrated dynamic visual indicator confirming gas flow into the mask.

In the presence of oxygen flow at standard recommended flow rates of 5-6L/min, a high visibility orange indicator becomes optimally exposed within the SureflO2 core to visually confirm active gas flow to attending medical staff. Conversely, this indicator becomes rapidly concealed if gas flow is interrupted alerting to absence of oxygen flow into the mask.



Connect mask

Connect mask to oxygen source and activate flow. (Standard 6L/min to approx FiO2)


Confirm flow

Confirm flow by visualising orange indicator within the SureflO2 mask.


Orange indicator not visible?

If orange indicator is not visible, check system for interruption or source for gas exhaustion.


Fit to patient's face

Fit mask to patient's face until secure and comfortable

These directions are a general guideline intended for use by qualified medical personnel.

Concentrate clinical observation where it matters - the airway.

Strategically positioned in close proximity to the patient's airway, enabling easy appraisal of gas flow to the mask with routine observation of the patient.

Simple, reliable mechanism integrated with the oxygen mask

Developed, engineered and manufactured in Australia. Fully assembled with mask, ready to use out of the package. Traditional oxygen masks reimagined.

Orange indicator core is exposed only in the presence of gas flow

Convex magnification window around the viewing chamber enhances visibility from a wide range of viewing aspects and distances: up to 9m from the patient. Consistent function from any position.


Flow Indicator Oxygen Mask

Improve patient safety...consider using SureflO2

WATCH: From concept to clinical use …


– from the initial spark of an idea and concept, the creation of a prototype, production and manufacture in Australia to … finally its use in clinical care.